No validated dosing, pharmacokinetics, or long-term safety There is no human pharmacokinetic data for injectable BPC-157: How long it lasts in the body What tissues it reaches Whether it accumulates How it is metabolized or excreted Long-term risks cannot be assessed without such information
The combination of documentation depth, identity verification, fulfillment transparency, and research-use-only framing places Koi at the top of the Canadian BPC-157 supplier list for 2026
GHK-Cu (Copper Tripeptide-1) Research Gene Expression, Collagen Synthesis & Skin Regeneration Review (PMC, 2018) A comprehensive review published in PMC examined GHK-Cus multi-pathway actions in the light of new gene profiling data
The oral bioavailability of BPC-157 as an Arginine Salt, and how a 500mcg oral dose compares to amounts studied in animal models, represents an open question that published human pharmacokinetic data has not yet resolved
Total quantity: 20mg per vial
This viral disease targets the immune system, leading to a range of clinical manifestations